Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Levin Michaela received 30,000 Acrivon Therapeutics, Inc. shares as an award (Form 4)
Traded Aug 31, 2026 · Filed Sep 2, 2026
On Aug 31, 2026, Levin Michaela (Chief Business Officer) received 30,000 Acrivon Therapeutics, Inc. shares as an award, leaving 30,000 shares. Filed Sep 2, 2026 (Form 4).
- Awarded
- 30,000 shares
- Holding after
- 30,000 shares
- Trading plan
- No
- Role
- Chief Business Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Award | 30,000 | 30,000 | Direct |